跳至主要内容
临床试验/RBR-863mw5z
RBR-863mw5z招募中3 期

Effects of Tranexamic Acid on mortality and transfusion rate in children undergoing Central Nervous System Tumor Resection Surgery: randomized, double-blind, placebo-controlled clinical trial

niversidade Federal de São Paulo0 个研究点开始时间: 2023年5月4日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 18Y(—)

入选标准

  • Patients from both genders; younger than 18 years old with a diagnosis of central nervous system tumor, characterized by radiological imaging (tomography or magnetic resonance imaging); whether it's their first surgery or reoperation due to relapse or progression; preoperative hemoglobin greater than 10mg/dl

排除标准

  • Patients over 18 years of age; patients with tumors in sites other than the intracranial compartment; patients with a history of hematological, liver, kidney, vascular diseases or who have had a previous thromboembolic event; patients who refuse to participate voluntarily will be excluded from the study; patients with epilepsy refractory to anticonvulsant medication (defined as the presence of seizures in a period of less than 12 months in patients with at least two anticonvulsants in an optimized dose); patients with tumors with a volume greater than 50% of a cerebral hemisphere

研究者

发起方
niversidade Federal de São Paulo

相似试验